3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Prostatic Neoplasms
3
Lymphoma
2
The Neoadjuvant Therapy
1
Sarcoma, Ewing
1
Sarcoma
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Interventions
Doxorubicin
3
Radiotherapy
2
Drug Therapy
2
pirarubicin
1
pazopanib
1
liposomal doxorubicin
1
capmatinib
1
anlotinib
1
Triptorelin Pamoate
1
Trabectedin
1
Radiation
1
Methotrexate
1
Ifosfamide
1
Fatty Acids, Omega-3
1
Cisplatin
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Sarcoma
×
Triptorelin Pamoate
×
Clear all
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled